Join our mailing list and receive the monthly BioVox newsletter for free!

RELATED ARTICLES
Trinean wins 25.000 euro for disposables production

Trinean won the “Time for a Boost 2015” competition organized by Test and Measurement Solutions. CEO Kurt Hensen handed a cheque of 25 000 euro to…


Congrats to Biocartis!

The Mechelen-based biotech company Biocartis starts its IPO adventure. The demand for shares was 6,5 times higher than the offer. Biocartis gather…


Got arthritis? DNAlytics has an app for it!

Approximately 30% of patients with undifferentiated arthritis develop rheumatoid arthritis - a chronic, inflammatory disease causing deformity of …

POPULAR TAGS

Coris BioConcept launches new rapid diagnostic platform

Written by DS on in the category news with the tags .


Coris BioConcept, a Walloon company specializing in in vitro diagnostics launched a new rapid diagnostic platform. It uses a novel microfluidic technology to conduct analyzes in multiplex mode. The platform allows to simultaneously identify multiple clinical parameters from a single blood or urine sample.

Thanks to the platform, the time to make a diagnosis can be shortened. The first applications of the platform will allow to identify the bacteria that cause sepsis and to determine whether these bacteria have antibiotic resistance. The platform is made up of an analytical instrument and microfluidic chips in which the tests are performed.

The Walloon Region (via BioWin) and the European program FP7 supported the development of this new diagnostic tool. The platform enables Coris BioConcept to position itself in the new market of rapid multiplex testing. The first two applications for the diagnosis of sepsis will be clinically validated later this year and will become available on the market within the next two years.

Founded in 1996, Coris BioConcept is a company active in the biotechnology sector and specializes in the development, production and marketing of rapid diagnostic tests. Coris BioConcept grows steadily since it was founded and is continually expanding its range of products, which are being sold in over 70 countries.

The main competitors in Belgium for this new diagnostic platform of Coris BioConcept are Roche  Diagnostics (Vilvoorde) and Biocartis (Mechelen), who presumably will place similar products on the market.

Read more about: .

RELATED ARTICLES
Trinean wins 25.000 euro for disposables production

Trinean won the “Time for a Boost 2015” competition organized by Test and Measurement Solutions. CEO Kurt Hensen handed a cheque of 25 000 euro to…


Congrats to Biocartis!

The Mechelen-based biotech company Biocartis starts its IPO adventure. The demand for shares was 6,5 times higher than the offer. Biocartis gather…


Got arthritis? DNAlytics has an app for it!

Approximately 30% of patients with undifferentiated arthritis develop rheumatoid arthritis - a chronic, inflammatory disease causing deformity of …

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

XpandInnovation Biowin UGent V-Bio Ventures Flanders.bio GSK Janssen Turnstone KU Leuven Itera Life Science

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.